Aytu Biopharma (AYTU) Total Debt Growth (1y) (2012 - 2026)
Aytu Biopharma (AYTU) Total Debt Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 41.53% |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | 2.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.12% |
| Dec 31, 2025 | 61.09% |
| Sep 30, 2025 | -16.30% |
| Jun 30, 2025 | 50.38% |
| Mar 31, 2025 | 620.56% |
| Dec 31, 2024 | -26.02% |
| Sep 30, 2024 | -1.37% |
| Jun 30, 2024 | -18.46% |
| Mar 31, 2024 | -89.24% |
| Dec 31, 2023 | 9.44% |
| Sep 30, 2023 | -35.44% |
| Jun 30, 2023 | -10.04% |
| Mar 31, 2023 | 2.97% |
| Dec 31, 2022 | 995.36% |
| Sep 30, 2022 | 393.95% |
| Jun 30, 2022 | 7.38% |
| Mar 31, 2022 | -11.93% |
| Dec 31, 2021 | -90.22% |
| Sep 30, 2021 | -59.74% |
| Jun 30, 2021 | 1,615.68% |